Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC

Brugnoli, Federica; Grassilli, Silvia; Lanuti, Paola; Marchisio, Marco; Al-Qassab, Yasamin; Vezzali, Federica; Capitani, Silvano; Bertagnolo, Valeria

doi:10.1186/s12885-017-3592-y

BMC Cancer

Article metrics
Last updated: Sun, 5 May 2024 0:16:45 Z

Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133⁺/EpCAM⁺ phenotype: a promising target for preventing progression of TNBC

Access & Citations

1644

Article Accesses
15

Web of Science
21

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com